Clinical Trial Update: A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular Degeneration [Phase 1, Phase 2]

View source ↗

Summary

EyeBiotech Ltd reports a two-part Phase 1/Phase 2 clinical trial evaluating safety in macular edema due to branch retinal vein occlusion and safety with prelimi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Branch Retinal Vein Occlusion
• Diabetic Macular Edema
• Neovascular Age-related Macular Degeneration

Snippet

Sponsor: EyeBiotech Ltd. | Conditions: Diabetic Macular Edema (DME), Neovascular Age-related Macular Degeneration (NVAMD) | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING